Sean Tucker | CSO
Vaxart
Dr. Tucker completed his doctoral degree in Immunology at the University of Washington. Dr. Tucker is the Chief Scientific Officer and Vice President for Research at Vaxart, Inc, a company focused on mucosal vaccine delivery. He has published several papers in immunology and served as a grant reviewer for several vaccine related study sections at the NIH.
Appearances:
Day 2 - Wednesday 15th October @ 15:45
Oral Covid Vaccine - Clinical Update from phase 1 to phase 2B
Session led by:
Day 2 - Wednesday 15th October @ 16:00
Oral bivalent vaccine for norovirus protection. Recent improvements to improve immunogenicity and potentially efficacy
Session led by:
Day 2 - Wednesday 15th October @ 16:00
Oral bivalent vaccine for norovirus protection. Recent improvements to improve immunogenicity and potentially efficacy
Session led by:
last published: 07/May/25 13:55 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events